Innovation Pharmaceuticals Inc (IPIX)

[58nout]

The 22 million dollar wager is thus: Insufficient liquidity may also require us to relinquish greater rights to product candidates at an earlier stage of development or on less favorable terms to us and our stockholders than we would otherwise choose in order to obtain up-front license fees needed to fund operations.

It would be foolish not to take this bet. Everyone here is well aware of the milestones to be reached over the next 12 months and what they imply.

Undoubtedly if the results of the clinical trials currently in process are as positive as we hope, the 22M will be money well spent.

Let it ride!